Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Condition(s) studied
Investigational drug(s) / intervention(s)
Colchicine 0.5 MG Oral Tablet: Oral intake of 0.5 mg colchicine once daily
Placebo: Oral intake of matching placebo once daily
Study summary
The main aim of this trial is to determine whether there are fewer cardiovascular events when patients with coronary artery disease take a low dose of colchicine of 0.5 mg daily on top of optimal standard treatment after treatment with PCI, compared with placebo in combination with optimal standard treatment. More specifically, we aim to investigate the benefits of a daily low dose of colchicine in patients with coronary artery disease after treatment with PCI, to confirm that a daily low dose of colchicine helps prevent additional incidents in coronary artery disease, and to identify a subgroup of patients with CAD who are at increased risk for cardiovascular events and could benefit most from colchicine.
Eligibility
Primary outcome measure(s)
- Time from randomisation to first occurrence of a composite endpoint consisting of: all-cause death, spontaneous (non-procedural) non-fatal myocardial infarction (Type 1, 4B & C), non-fatal stroke, or coronary revascularisation. — 44 months
Trial sites (19)
| Facility | City | Region | Status |
|---|---|---|---|
| Algemeen Stedelijk Ziekenhuis Campus Aalst | Aalst | Belgium | Recruiting |
| Het Ziekenhuisnetwerk Antwerpen | Antwerp | Belgium | Recruiting |
| Universitair Ziekenhuis Antwerpen | Antwerp | Belgium | Recruiting |
| Imelda | Bonheiden | Belgium | Recruiting |
| AZ Sint-Jan Brugge-Oostende AV | Bruges | Belgium | Recruiting |
| Humani Charleroi | Charleroi | Belgium | Recruiting |
| Grand Hôpital de Charleroi | Charleroi | Belgium | Not Yet Recruiting |
| Ziekenhuis Oost Limburg | Genk | Belgium | Recruiting |
| AZ Sint-Lucas & Volkskliniek | Ghent | Belgium | Recruiting |
| Universitair Ziekenhuis Gent | Ghent | Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt | Belgium | Recruiting |
| Algemeen Ziekenhuis Groeninge | Kortrijk | Belgium | Recruiting |
| UZ Leuven | Leuven | Belgium | Recruiting |
| Centre Hospitalier Regional De La Citadelle | Liège | Belgium | Recruiting |
| Clinique Saint-Luc Bouge | Namur | Belgium | Recruiting |
| AZ Delta | Roeselare | Belgium | Recruiting |
| AZ Turnhout | Turnhout | Belgium | Recruiting |
| Cliniques Universitaires Saint-Luc | Woluwe-Saint-Lambert | Belgium | Recruiting |
| UCL Mont-Godinne | Yvoir | Belgium | Recruiting |
More AZ Sint-Jan AV trials in Belgium
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06095765 on ClinicalTrials.gov ↗ ← All trials in Belgium